Baidu
map

梅斯医学作为媒体合作单位参与2016世界胸科大会

2016-04-14 梅斯医学 2016世界胸科大会

由美国胸科医师协会 (CHEST) 携手中华医学会呼吸病学分会,共同打造的 2016 世界胸科大会将于2016年4月15日到17日在中国上海隆重举行。这场最顶级的临床盛会,为胸科医师、危重症医师、睡眠医学专家、及其他领域的医师们集中展示最先进的现场模拟操作演示课程、基于实际疑难病例的演讲、及循证医学方面的精彩内容。大会为参会者提供了与CHEST全球年会类似的创新、多元化的教育机会,以及与来自世界各



由美国胸科医师协会 (CHEST) 携手中华医学会呼吸病学分会,共同打造的 2016 世界胸科大会将于2016年4月15日到17日在中国上海隆重举行。这场最顶级的临床盛会,为胸科医师、危重症医师、睡眠医学专家、及其他领域的医师们集中展示最先进的现场模拟操作演示课程、基于实际疑难病例的演讲、及循证医学方面的精彩内容。大会为参会者提供了与CHEST全球年会类似的创新、多元化的教育机会,以及与来自世界各地的知名专家面对面交流的平台,并将整合原创性研究和指南推荐。这一国际性盛会将汇集来自中国、北美、及全球其它地区的最具思想的胸科专家,相互学习和交流,推动胸科医学不断发展。

会议时间:2016年4月15-4月17日
会议地点:上海国际会议中心(上海浦东滨江大道 2727 号)
主办单位:美国胸科医师协会(CHEST)和中华医学会呼吸病学分会 

大会课程预告

一、研究生课程(需要在正式会议之外另行注册)

1. 晚期机械通气

呼吸衰竭、重度低氧血症、阻塞性肺病和人机对抗都是临床实践中难以处理的问题。本课程将会审核在这些棘手的临床情景中优化机械通气的方法, 检查支持不同呼吸器模式和患者管理的证据。

2. 临床肺部医学: 临床案例回顾

与专家们一同讨论当前胸科的相关话题。通过实例分析,你将审视重要的临床话题方面的新知识和循证推荐,其中包括 COPD、弥漫性肺疾病、肺动脉高血压、 肺癌和肺部感染。

3. 肺癌治疗的教学计划: 一个以多学科团队为基础的方案

以团队的方式审查肺癌诊断和管理。通过 EBUS-TBNA、 涂片制备、样本制备、病理分析和分子标记等,获得实际操作经验。这一以问题为导向的学习和练习, 为基于患者的临床情景提供了一个思考框架。

4. 肺疾病胸部超声学检查以及急救护理咨询

与经验丰富的专家一同进行实际图像采集、图像判读和胸超声检查的临床应用,并参与到实时示范扫描、实例讨论和利用人体模型和最新超声技术进行的实践小组培训中来。

二、正式会议

专家们将探讨各种临床话题。您可以从中吸取各种观点,从而对全球的医疗健康状况有一个综合性的理解。



三、CHEST 现场模拟操作演示中心

1. 超声评估心肺功能衰竭

2. 支气管镜检查流程

3. 机械通气: 危重患者优化护理技术

4. 呼吸睡眠综合征的家庭检测

5. 先进的气道正压设备及下载

6. 肺功能检查: 基于实例,亲身实践,基于指南的实习

四、基于实际问题的学习单元

这一互动环节将以小组形式来研究和探讨临床案例,能有效地锻炼您的批判性思维,并加强对 CHEST 循证指南中的建议的执行。大会参会者可以免费参加本学习单元,但需在填写大会注册信息时,额外注册本单元。

五、原创性研究

未发布过的具有突破性的科学研究新闻, 将在这里以壁报和 PPT 的形式首次公开展示。

六、案例报告

我们将收集全球范围内的有趣、相关、或不同寻常的案例,并在专家的主持下,和大家一同探讨。

七、临床案例难点

由医师、放射学专家、病理学家带领大家一同研究和探讨异常的或难以管理的真实案例, 以检验和加强影像学和病理发现之间的相互关系。

会议信息

注册时间
4月14日星期四 • 15:00 - 18:00
4月15日星期五 • 7:00 - 17:00
4月16日星期六 • 7:30 - 17:00
4月17日星期日 • 7:30 - 12:00

梅斯医学作为本次会议的媒体合作单位将为您全程实时报道,敬请关注!(点击下载梅斯医学APP

“梅斯医生”,一款重新定义医学继续教育模式的产品。为解决年轻医生职业成长、临床经验的积累提供了全面的解决方案。通过虚拟现实技术,将患者就诊过程和医师检查及诊断过程虚拟化,用户通过与虚拟患者的交互,进行模拟的病情采集及诊疗,能让临床医生在较短时间内接解到大量的复杂的病患,不断模拟最佳的临床诊疗路径,提高诊疗的精准性。

梅斯医生将于4月22日正式上线,欢迎大家参与!

“梅斯医生”体验馆

在发布会现场,专门设置“梅斯医生”体验馆,用一个小小的眼镜,带你“上天入地”,亲身体验科技带来的震感!

4月22日,不见不散,点击链接,直接报名参加发布会://m.capotfarm.com/z/msys/mt.html

欢迎关注CHEST微信公众号,了解大会最近动态


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1276802, encodeId=004f12e68025b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 16 03:29:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78365, encodeId=6dd4e8365ee, content=支持,好多点哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xSHQO6hUsLfmSqiaQiceT0D77ib0rXiblAIwyTo0iciakSAGHE0nfEpNHl9icHMY6tKTW3kFdWSwKcWGvneZHicqoJsI5V/0, createdBy=2a221626427, createdName=王新春, createdTime=Thu Apr 14 20:31:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78357, encodeId=6d5ae8357af, content=支持梅斯医学,好样的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Apr 14 19:08:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77851, encodeId=e17ce785104, content=高大上,支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77852, encodeId=cb20e785265, content=胸科,呼吸…, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77832, encodeId=1c48e783278, content=高大尚的会议, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d231626576, createdName=jjzouyan, createdTime=Thu Apr 14 13:53:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77820, encodeId=13aee782090, content=值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Apr 14 13:05:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-16 一闲
  2. [GetPortalCommentsPageByObjectIdResponse(id=1276802, encodeId=004f12e68025b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 16 03:29:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78365, encodeId=6dd4e8365ee, content=支持,好多点哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xSHQO6hUsLfmSqiaQiceT0D77ib0rXiblAIwyTo0iciakSAGHE0nfEpNHl9icHMY6tKTW3kFdWSwKcWGvneZHicqoJsI5V/0, createdBy=2a221626427, createdName=王新春, createdTime=Thu Apr 14 20:31:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78357, encodeId=6d5ae8357af, content=支持梅斯医学,好样的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Apr 14 19:08:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77851, encodeId=e17ce785104, content=高大上,支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77852, encodeId=cb20e785265, content=胸科,呼吸…, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77832, encodeId=1c48e783278, content=高大尚的会议, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d231626576, createdName=jjzouyan, createdTime=Thu Apr 14 13:53:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77820, encodeId=13aee782090, content=值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Apr 14 13:05:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-14 王新春

    支持,好多点哦!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1276802, encodeId=004f12e68025b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 16 03:29:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78365, encodeId=6dd4e8365ee, content=支持,好多点哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xSHQO6hUsLfmSqiaQiceT0D77ib0rXiblAIwyTo0iciakSAGHE0nfEpNHl9icHMY6tKTW3kFdWSwKcWGvneZHicqoJsI5V/0, createdBy=2a221626427, createdName=王新春, createdTime=Thu Apr 14 20:31:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78357, encodeId=6d5ae8357af, content=支持梅斯医学,好样的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Apr 14 19:08:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77851, encodeId=e17ce785104, content=高大上,支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77852, encodeId=cb20e785265, content=胸科,呼吸…, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77832, encodeId=1c48e783278, content=高大尚的会议, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d231626576, createdName=jjzouyan, createdTime=Thu Apr 14 13:53:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77820, encodeId=13aee782090, content=值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Apr 14 13:05:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-14 lovetcm

    支持梅斯医学,好样的。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1276802, encodeId=004f12e68025b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 16 03:29:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78365, encodeId=6dd4e8365ee, content=支持,好多点哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xSHQO6hUsLfmSqiaQiceT0D77ib0rXiblAIwyTo0iciakSAGHE0nfEpNHl9icHMY6tKTW3kFdWSwKcWGvneZHicqoJsI5V/0, createdBy=2a221626427, createdName=王新春, createdTime=Thu Apr 14 20:31:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78357, encodeId=6d5ae8357af, content=支持梅斯医学,好样的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Apr 14 19:08:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77851, encodeId=e17ce785104, content=高大上,支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77852, encodeId=cb20e785265, content=胸科,呼吸…, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77832, encodeId=1c48e783278, content=高大尚的会议, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d231626576, createdName=jjzouyan, createdTime=Thu Apr 14 13:53:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77820, encodeId=13aee782090, content=值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Apr 14 13:05:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-14 李继凯

    高大上,支持

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1276802, encodeId=004f12e68025b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 16 03:29:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78365, encodeId=6dd4e8365ee, content=支持,好多点哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xSHQO6hUsLfmSqiaQiceT0D77ib0rXiblAIwyTo0iciakSAGHE0nfEpNHl9icHMY6tKTW3kFdWSwKcWGvneZHicqoJsI5V/0, createdBy=2a221626427, createdName=王新春, createdTime=Thu Apr 14 20:31:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78357, encodeId=6d5ae8357af, content=支持梅斯医学,好样的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Apr 14 19:08:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77851, encodeId=e17ce785104, content=高大上,支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77852, encodeId=cb20e785265, content=胸科,呼吸…, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77832, encodeId=1c48e783278, content=高大尚的会议, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d231626576, createdName=jjzouyan, createdTime=Thu Apr 14 13:53:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77820, encodeId=13aee782090, content=值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Apr 14 13:05:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-14 李继凯

    胸科,呼吸…

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1276802, encodeId=004f12e68025b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 16 03:29:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78365, encodeId=6dd4e8365ee, content=支持,好多点哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xSHQO6hUsLfmSqiaQiceT0D77ib0rXiblAIwyTo0iciakSAGHE0nfEpNHl9icHMY6tKTW3kFdWSwKcWGvneZHicqoJsI5V/0, createdBy=2a221626427, createdName=王新春, createdTime=Thu Apr 14 20:31:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78357, encodeId=6d5ae8357af, content=支持梅斯医学,好样的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Apr 14 19:08:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77851, encodeId=e17ce785104, content=高大上,支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77852, encodeId=cb20e785265, content=胸科,呼吸…, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77832, encodeId=1c48e783278, content=高大尚的会议, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d231626576, createdName=jjzouyan, createdTime=Thu Apr 14 13:53:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77820, encodeId=13aee782090, content=值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Apr 14 13:05:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-14 jjzouyan

    高大尚的会议

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1276802, encodeId=004f12e68025b, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Sat Apr 16 03:29:00 CST 2016, time=2016-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78365, encodeId=6dd4e8365ee, content=支持,好多点哦!, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xSHQO6hUsLfmSqiaQiceT0D77ib0rXiblAIwyTo0iciakSAGHE0nfEpNHl9icHMY6tKTW3kFdWSwKcWGvneZHicqoJsI5V/0, createdBy=2a221626427, createdName=王新春, createdTime=Thu Apr 14 20:31:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=78357, encodeId=6d5ae8357af, content=支持梅斯医学,好样的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Thu Apr 14 19:08:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77851, encodeId=e17ce785104, content=高大上,支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77852, encodeId=cb20e785265, content=胸科,呼吸…, beContent=null, objectType=article, channel=null, level=null, likeNumber=139, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=240a1683959, createdName=李继凯, createdTime=Thu Apr 14 17:22:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77832, encodeId=1c48e783278, content=高大尚的会议, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0d231626576, createdName=jjzouyan, createdTime=Thu Apr 14 13:53:00 CST 2016, time=2016-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=77820, encodeId=13aee782090, content=值得关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Thu Apr 14 13:05:00 CST 2016, time=2016-04-14, status=1, ipAttribution=)]
    2016-04-14 dhzzm

    值得关注。

    0

相关资讯

执医考试报名开始了,即日起至3月17日!注意事项看过来!

近期,国家医学考试网公布了2016年执业医师资格考试报名的截止日期。今年打算考执业的医生们请注意报名时间,报名注意事项!不要错过了,快转给您身边准备考试的朋友吧! 网上报名时间:自公告发布之日起至2016年3月17日24:00。 一、网上报名方法: 1.建议使用IE8.0以上版本浏览器,输入法选择简体中文-半角。 2.登陆网址方法一:直接点击链接,登陆国家医

两会:2016 医疗热点问题抢先看!

2016年全国两会于今天下午3点在北京人民大会堂开幕,俞正声代表政协第十二届全国委员会常务委员会作工作报告。发言提到将就健康教育,医疗等热点问题开展全面调研,对中国仿制药质量,中医药发展,转基因食品安全等问题进一步加强关注。此次两会将持续至3月14日,梅斯医学新媒体编辑部将同生物医药领域人员一起关注两会医药卫生领域的新发展。 那么作为全面建成小康社会决胜阶段的第一次全国两会,网民最关

ENDO 2016:只有1%的符合条件的患者在使用减肥药

内分泌学会年会上称,根据对电子健康记录分析后显示,治疗肥胖的药物的处方率仍然很低,只有1%的符合条件的患者使用药物治疗方案,并且处方提供者的处方率存在巨大的变异。科罗拉多州大学和丹佛健康医疗中心内分泌学教授Daniel Bessesen博士说:“虽然有权威的指南,但是符合减肥药物的条件的患者中,药物的处方率十分低。这与其他慢性代谢性疾病如糖尿病和高血压的境况不同,那两种疾病的处方率在50-80%范

转化医学前沿:2016年美国临床与转化医学年会将探讨什么?

精彩演讲:NASA推进转化医学进入太空医学最佳实践:新药申请和研究性器械的豁免申请法规科学:FDA从审评规范到法规科学发展导读年年四月樱花节,美国临床与转化医学学会也一如既往年年在华盛顿的Omni 酒店举行。为满足国内临床与转化医学领域专家同仁的期盼,早点儿了解年会主题、热点和亮点,我们整理了仍在酝酿中的转化医学年会活动日程,与各位分享一下。美国转化医学已开始探讨“太空的事儿了!”今年年会主题之一

Baidu
map
Baidu
map
Baidu
map